ArticleJournal of cellular and molecular medicine2021

CDX2 enhances natural killer cell-mediated immunotherapy against head and neck squamous cell carcinoma through up-regulating CXCL14.

Haitao Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.